Gyre Therapeutics, Inc. GYRE Increase Decrease In Due To Related Parties
Increase Decrease In Due To Related Parties at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDueToRelatedParties.
The official record: Gyre Therapeutics, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s increase decrease in due to related parties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s increase decrease in due to related parties?
- Gyre Therapeutics, Inc. (GYRE) reported increase decrease in due to related parties of -$250 in Q4 2025.
- How has Gyre Therapeutics, Inc.'s increase decrease in due to related parties changed year-over-year?
- Gyre Therapeutics, Inc.'s increase decrease in due to related parties increased by 75.0% year-over-year, from -$1K to -$250.
- What does increase decrease in due to related parties mean?
- This metric represents the net change in outstanding balances owed to affiliated entities or related parties during the reporting period. It reflects the company's short-term financing or operational interactions with entities under common control or significant influence. Monitoring this helps investors assess potential conflicts of interest or the reliance on related-party funding for working capital needs.